It produces and releases enzymes and hormones needed to digest food, and a small part of the pancreas also produces and releases insulin
Materials and methods: Glucagon-like peptide-1 receptor (GLP-1R) kinetic binding parameters, cyclic adenosine monophosphate (cAMP) signalling, endocytosis and recycling were measured using HEK293 and INS-1832/3 cells expressing human GLP-1R
Metabolites , 13(4), 465
Experimental models of colitis have demonstrated that KPV reduces mucosal damage, promotes tissue repair, and limits systemic inflammation without broadly suppressing immune function
Wegovy is GLP-1 only this explains the difference Side effects are very similar primarily gastrointestinal, worst during dose escalation Wegovy has an FDA cardiovascular benefit and now an oral tablet option Zepbound is generally cheaper at list price (~$1,086 vs ~$1,349/month) Both drop to ~$25/month with commercial insurance savings cards Neither is covered by Medicare/Medicaid for weight loss alone in 2026 The right choice depends on your health profile , insurance, and tolerance not just the weight loss numbers References Aronne LJ, et al
2018 Jan;33(1):54-62
